(Q43588086)

English

Thiazolidinediones and cardiovascular events in patients with type 2 diabetes mellitus: a retrospective cohort study of over 473,000 patients using the National Health Insurance database in Taiwan

scientific article published in January 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 November 2017

Thiazolidinediones and cardiovascular events in patients with type 2 diabetes mellitus: a retrospective cohort study of over 473,000 patients using the National Health Insurance database in Taiwan (English)

1 reference

Europe PubMed Central

24 November 2017

type 2 diabetes

1 reference

based on heuristic

inferred from title

object named as

Fei-Yuan Hsiao

1

0 references

author name string

Weng-Foung Huang

2

1 reference

Europe PubMed Central

24 November 2017

Yu-Wen Wen

3

1 reference

Europe PubMed Central

24 November 2017

Pei-Fen Chen

4

1 reference

Europe PubMed Central

24 November 2017

Ken N Kuo

5

1 reference

Europe PubMed Central

24 November 2017

Yi-Wen Tsai

6

1 reference

Europe PubMed Central

24 November 2017

publication date

1 January 2009

1 reference

Europe PubMed Central

24 November 2017

1 reference

Europe PubMed Central

24 November 2017

32

1 reference

Europe PubMed Central

24 November 2017

8

1 reference

Europe PubMed Central

24 November 2017

675-690

1 reference

Europe PubMed Central

24 November 2017

https://scigraph.springernature.com/pub.10.2165/00002018-200932080-00006

0 references

Uncertain effects of rosiglitazone on the risk for myocardial infarction and cardiovascular death

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200932080-00006

21 January 2018

The risk of coronary heart disease in type 2 diabetic patients exposed to thiazolidinediones compared to metformin and sulfonylurea therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19591532

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antidiabetic drugs and heart failure risk in patients with type 2 diabetes in the U.K. primary care setting

1 reference

https://pubmed.ncbi.nlm.nih.gov/19591532

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive 05) Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19591532

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular outcomes in trials of oral diabetes medications: a systematic review

1 reference

https://pubmed.ncbi.nlm.nih.gov/19591532

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19591532

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The record on rosiglitazone and the risk of myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/19591532

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coronary heart disease outcomes in patients receiving antidiabetic agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/19591532

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/19591532

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19591532

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Challenges in meta-analysis of randomized clinical trials for rare harmful cardiovascular events: the case of rosiglitazone

1 reference

https://pubmed.ncbi.nlm.nih.gov/19591532

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19591532

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pioglitazone initiation and subsequent hospitalization for congestive heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/19591532

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thiazolidinediones and cardiovascular outcomes in older patients with diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/19591532

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Excess mortality in a population with diabetes and the impact of material deprivation: longitudinal, population based study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19591532

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of pioglitazone and rosiglitazone for hospitalization for acute myocardial infarction in type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/19591532

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association between congestive heart failure and hospitalization in patients with type 2 diabetes mellitus receiving treatment with insulin or pioglitazone: a retrospective data analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19591532

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/19591532

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

1 reference

https://pubmed.ncbi.nlm.nih.gov/19591532

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of cardiovascular outcomes in elderly patients with diabetes who initiated rosiglitazone vs pioglitazone therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19591532

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19591532

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thiazolidinediones in type 2 diabetes mellitus: current clinical evidence

1 reference

https://pubmed.ncbi.nlm.nih.gov/19591532

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00002018-200932080-00006

1 reference

Europe PubMed Central

24 November 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

24 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43588086&oldid=2101710657"